Determining the pathophysiology of autoimmune thyroid disease can be challenging, especially in the early stages. In this short post, we provide some ways to differentiate the 2.
Both disorders may initially present with low TSH. In Grave’s disease, an overactive thyroid and an overabundance of thyroid hormones signal the pituitary to produce less TSH (Taylor 2018). However, in early Hashimoto’s, the TSH may be low due to thyrotoxicosis or “Hashitoxicosis.” In this case, damage to thyroid cells causes a release of preformed thyroid hormone, which signals the pituitary to produce less TSH (Shahbaz 2018).
Additional studies, including thyroid antibody testing, can help evaluate the clinical picture (Pagana 2021, Ross 2016, Frohlich 2017):
Fröhlich, Eleonore, and Richard Wahl. “Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases.” Frontiers in immunology vol. 8 521. 9 May. 2017, doi:10.3389/fimmu.2017.00521
Iqbal, Aqsa. and Anis Rehman. “Thyroid Uptake and Scan.” StatPearls, StatPearls Publishing, 3 October 2022.
Pagana, Kathleen Deska, et al. Mosby's Diagnostic and Laboratory Test Reference. 15th ed., Mosby, 2021.
Ross, Douglas S et al. “2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.” Thyroid : official journal of the American Thyroid Association vol. 26,10 (2016): 1343-1421. doi:10.1089/thy.2016.0229
Shahbaz, Amir et al. “Prolonged Duration of Hashitoxicosis in a Patient with Hashimoto's Thyroiditis: A Case Report and Review of Literature.” Cureus vol. 10,6 e2804. 14 Jun. 2018, doi:10.7759/cureus.2804
Taylor, Peter N et al. “Global epidemiology of hyperthyroidism and hypothyroidism.” Nature reviews. Endocrinology vol. 14,5 (2018): 301-316. doi:10.1038/nrendo.2018.18